Catalent unveils new formulation service; Icon mounts a share buyback;

> Catalent ($CTLT) has introduced OptiPact, a new formulation offering that taps the company's roller compaction technology for drug manufacturing. More

> Icon ($ICON) wrapped up a $40 million share buyback, clearing the way to acquire $100 million more as it looks to optimize its capital structure. News